BOLT - Bolt Biotherapeutics Inc. (BOLT) Q1 2024 Earnings Call Transcript
2024-05-17 20:37:07 ET
Bolt Biotherapeutics, Inc. (BOLT)
Q1 2024 Earnings Conference Call
May 14, 2024 04:30 PM ET
Company Participants
Willie Quinn - Incoming Chief Executive Officer
Randy Schatzman - Outgoing Chief Executive Officer
Edith Perez - Outgoing Chief Medical Officer
Michael Alonso - Co-Founder of Bolt and Senior Vice President of Research
Dawn Colburn - Senior Vice President of Clinical Development.
Conference Call Participants
Jeffrey La Rosa - Leerink Partners
Stephen Willey - Stifel
Michael Schmidt - Guggenheim
Presentation
Operator
Good afternoon, and welcome to the Bolt Biotherapeutics Strategic Update Conference Call. At this time, all participants are in a listen only mode. After the speakers’ presentation, we will conduct a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be recorded.
I would now like to hand the call over to Willie Quinn, incoming Chief Executive Officer of Bolt Biotherapeutics. Please go ahead, sir.
Willie Quinn
Thank you, and good afternoon, everyone. This afternoon, we issued our first quarter 2024 financial results and business update, which outlines the topics we plan to discuss today. You can access the press release by going to the Investors and Media section of our website at www.boltbio.com....
Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript